Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
CHRS•Company initiates sale process for legacy biosimilar assets
Sept. 23 (Reuters) - Coherus Oncology Inc. CHRS.O:
- Coherus Oncology initiates process to sell legacy biosim assets.
Source text: ID:nGNXbsSlwz
Further company coverage: CHRS.O




